- Home
- COO vs RVNC Comparison
COO vs RVNC Comparison
Compare COO & RVNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COO
- RVNC
- Stock Information
- Founded
- COO 1980
- RVNC 1999
- Country
- COO United States
- RVNC United States
- Employees
- COO N/A
- RVNC N/A
- Industry
- COO Ophthalmic Goods
- RVNC Biotechnology: Pharmaceutical Preparations
- Sector
- COO Health Care
- RVNC Health Care
- Exchange
- COO Nasdaq
- RVNC Nasdaq
- Market Cap
- COO N/A
- RVNC 546.4M
- IPO Year
- COO N/A
- RVNC 2014
- Fundamental
- Price
- COO $106.74
- RVNC $5.28
- Analyst Decision
- COO Strong Buy
- RVNC Buy
- Analyst Count
- COO 13
- RVNC 10
- Target Price
- COO $115.00
- RVNC $10.86
- AVG Volume (30 Days)
- COO 1.0M
- RVNC 3.6M
- Earning Date
- COO 12-05-2024
- RVNC 11-06-2024
- Dividend Yield
- COO 0.01%
- RVNC N/A
- EPS Growth
- COO 30.26
- RVNC N/A
- EPS
- COO 1.80
- RVNC N/A
- Revenue
- COO $3,804,100,000.00
- RVNC $251,178,000.00
- Revenue This Year
- COO $9.76
- RVNC $20.36
- Revenue Next Year
- COO $7.61
- RVNC $31.66
- P/E Ratio
- COO $59.38
- RVNC N/A
- Revenue Growth
- COO 8.25
- RVNC 40.23
- 52 Week Low
- COO $75.94
- RVNC $2.30
- 52 Week High
- COO $112.38
- RVNC $9.90
- Technical
- Relative Strength Index (RSI)
- COO 51.92
- RVNC 39.70
- Support Level
- COO $104.91
- RVNC $5.13
- Resistance Level
- COO $106.91
- RVNC $5.41
- Average True Range (ATR)
- COO 1.64
- RVNC 0.20
- MACD
- COO -0.79
- RVNC -0.02
- Stochastic Oscillator
- COO 28.02
- RVNC 42.19
About RVNC Revance Therapeutics Inc.
Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.